The results demonstrated that in hypoxic pancreatic cancer cells, curcumin downregulates Beclin1 expression and inhibits HIF-1α-mediated glycolysis, thereby inhibiting pancreatic cancer cell proliferation. Here, BECN1 is linked to familial pancreatic carcinoma.